APLP2 and familial pancreatic carcinoma: Among the pancreatic cancer cell lines that we examined, 4 out of 5 expressed high levels of endogenous chondroitin sulfate glycosaminoglycan-modified APLP2 [42], which suggests that there may be preferential expression in pancreatic cancer cells of APLP2 isoforms lacking exon 14.